{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:55:18Z","timestamp":1790823318471,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Internal hospital fund of the affiliated Guangdong Second Provincial General Hospital of Jinan University","award":["YN2024-005"],"award-info":[{"award-number":["YN2024-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00882-5","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:43:50Z","timestamp":1783442630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ALDH18A1 silencing inhibits lung adenocarcinoma progression through mitochondrial dysfunction and PPAR signaling pathway activation"],"prefix":"10.1186","volume":"21","author":[{"given":"Taixu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"3","key":"882_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"key":"882_CR2","doi-asserted-by":"publisher","first-page":"102693","DOI":"10.1016\/j.canep.2024.102693","volume":"93","author":"J Zhou","year":"2024","unstructured":"Zhou J, et al. Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. 2024;93:102693.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"882_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","volume":"10","author":"LE Hendriks","year":"2024","unstructured":"Hendriks LE, et al. Non-small-cell lung cancer. Nat Reviews Disease Primers. 2024;10(1):71.","journal-title":"Nat Reviews Disease Primers"},{"issue":"3","key":"882_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1183\/13993003.00359-2016","volume":"48","author":"J Malhotra","year":"2016","unstructured":"Malhotra J, et al. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48(3):889\u2013902.","journal-title":"Eur Respir J"},{"key":"882_CR5","doi-asserted-by":"crossref","unstructured":"Deng X, et al. The role of TGFBR3 in the development of lung cancer. Protein Pept Lett. Netherlands; 2024;491\u2013503.","DOI":"10.2174\/0109298665315841240731060636"},{"key":"882_CR6","doi-asserted-by":"crossref","unstructured":"Qian XJ, et al. The mediating role of miR-451\/ETV4\/MMP13 signaling axis on epithelialmesenchymal transition in promoting non-small cell lung cancer progression. Curr Mol Pharmacol. Netherlands; 2024. p. e210723218988.","DOI":"10.2174\/1874467217666230721123554"},{"key":"882_CR7","doi-asserted-by":"crossref","unstructured":"Ullah A, et al. Sanguinarine attenuates lung cancer progression via oxidative stress-induced cell apoptosis. Curr Mol Pharmacol. Netherlands; 2024. p. e18761429269383.","DOI":"10.2174\/0118761429269383231119062233"},{"key":"882_CR8","doi-asserted-by":"crossref","unstructured":"Chandel NS. Mitochondria. Cold spring harbor perspectives in biology. 2021;13(3): p. a040543.","DOI":"10.1101\/cshperspect.a040543"},{"issue":"1","key":"882_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","volume":"15","author":"P Jin","year":"2022","unstructured":"Jin P, et al. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol. 2022;15(1):97.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"882_CR10","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","volume":"26","author":"HL Glover","year":"2024","unstructured":"Glover HL, et al. Mitochondria and cell death. Nat Cell Biol. 2024;26(9):1434\u201346.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"882_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/membranes12090893","volume":"12","author":"M Al Ojaimi","year":"2022","unstructured":"Al Ojaimi M, Salah A, El-Hattab AW. Mitochondrial fission and fusion: molecular mechanisms, biological functions, and related disorders. Membranes. 2022;12(9):893.","journal-title":"Membranes"},{"issue":"16","key":"882_CR12","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.3390\/cancers16162823","volume":"16","author":"A Dutkowska","year":"2024","unstructured":"Dutkowska A, et al. Mitochondrial Dynamics in Non-Small Cell Lung Cancer. Cancers. 2024;16(16):2823.","journal-title":"Cancers"},{"issue":"7","key":"882_CR13","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/2211-5463.13207","volume":"11","author":"D Liu","year":"2021","unstructured":"Liu D, et al. The mitochondrial fission factor FIS1 promotes stemness of human lung cancer stem cells via mitophagy. FEBS open bio. 2021;11(7):1997\u20132007.","journal-title":"FEBS open bio"},{"key":"882_CR14","doi-asserted-by":"crossref","unstructured":"Jalees R, et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J. 2012;26(5).","DOI":"10.1096\/fj.11-196543"},{"key":"882_CR15","doi-asserted-by":"publisher","first-page":"154338","DOI":"10.1016\/j.metabol.2020.154338","volume":"114","author":"A Christofides","year":"2021","unstructured":"Christofides A, et al. The role of peroxisome proliferator-activated receptors (PPAR) in immune responses. Metabolism. 2021;114:154338.","journal-title":"Metabolism"},{"issue":"4","key":"882_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/exd.14072","volume":"29","author":"M Grabacka","year":"2020","unstructured":"Grabacka M, Plonka PM, Reiss K. Melanoma-Time to fast or time to feast? An interplay between PPARs, metabolism and immunity. Exp Dermatol. 2020;29(4):436\u201345.","journal-title":"Exp Dermatol"},{"issue":"4","key":"882_CR17","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cmet.2014.08.003","volume":"20","author":"N Srivastava","year":"2014","unstructured":"Srivastava N, et al. Inhibition of cancer cell proliferation by PPARgamma is mediated by a metabolic switch that increases reactive oxygen species levels. Cell Metab. 2014;20(4):650\u201361.","journal-title":"Cell Metab"},{"key":"882_CR18","doi-asserted-by":"crossref","unstructured":"Fujiwara M, et al. Mitochondrial metabolism as a potential novel therapeutic target for lung adenocarcinoma. In Anticancer Res. Greece; 2024;5241\u201352.","DOI":"10.21873\/anticanres.17352"},{"issue":"1","key":"882_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41598-021-04664-z","volume":"12","author":"C Cava","year":"2022","unstructured":"Cava C, et al. Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes. Sci Rep. 2022;12(1):693.","journal-title":"Sci Rep"},{"issue":"1","key":"882_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12672-024-01698-3","volume":"16","author":"H Ren","year":"2025","unstructured":"Ren H, et al. Integrated bioinformatics analysis identifies ALDH18A1 as a prognostic hub gene in glutamine metabolism in lung adenocarcinoma. Discover Oncol. 2025;16(1):1.","journal-title":"Discover Oncol"},{"issue":"1","key":"882_CR21","doi-asserted-by":"publisher","first-page":"9259297","DOI":"10.1155\/2021\/9259297","volume":"2021","author":"Z Ye","year":"2021","unstructured":"Ye Z, et al. Comprehensive analysis of alteration landscape and its clinical significance of mitochondrial energy metabolism pathway-related genes in lung cancers. Oxidative Med Cell Longev. 2021;2021(1):9259297.","journal-title":"Oxidative Med Cell Longev"},{"issue":"4","key":"882_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"key":"882_CR23","doi-asserted-by":"crossref","unstructured":"Linder SJ, et al. Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells. Nat Metab. Germany; 2023;2131\u201347.","DOI":"10.1038\/s42255-023-00919-3"},{"key":"882_CR24","doi-asserted-by":"crossref","unstructured":"Han T, et al. Phosphorylated SHMT2 regulates oncogenesis through m(6)A modification in lung adenocarcinoma. Adv Sci (Weinh). Germany; 2024. p. e2307834.","DOI":"10.1002\/advs.202307834"},{"key":"882_CR25","doi-asserted-by":"crossref","unstructured":"Li Y, et al. Genome-scale CRISPR-Cas9 screen identifies PAICS as a therapeutic target for EGFR wild-type non-small cell lung cancer. MedComm (2020). China; 2024. p. e483.","DOI":"10.2139\/ssrn.4430749"},{"issue":"2","key":"882_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clnu.2023.12.005","volume":"43","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression. Clin Nutr. 2024;43(2):332\u201345.","journal-title":"Clin Nutr"},{"issue":"4\u20136","key":"882_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/ars.2023.0442","volume":"41","author":"C Kaur","year":"2024","unstructured":"Kaur C, et al. Targeting Peroxisome Proliferator-Activated Receptor-beta\/delta, Reactive Oxygen Species and Redox Signaling with Phytocompounds for Cancer Therapy. Antioxid Redox Signal. 2024;41(4\u20136):342\u201395.","journal-title":"Antioxid Redox Signal"},{"key":"882_CR28","doi-asserted-by":"crossref","unstructured":"Zhang J, et al. Off-target engagement of sotorasib with PPARgamma via FABP4: a novel mechanism driving interstitial lung disease. In Cell Commun Signal. England; 2025, p. 416.","DOI":"10.1186\/s12964-025-02425-3"},{"key":"882_CR29","doi-asserted-by":"crossref","unstructured":"Tabara LC, Segawa M, Prudent J. Molecular mechanisms of mitochondrial dynamics. Nat Rev Mol Cell Biol. 2025;123\u2013146.","DOI":"10.1038\/s41580-024-00785-1"},{"key":"882_CR30","doi-asserted-by":"crossref","unstructured":"Liang X, Dang S. Mitochondrial dynamics related genes -MFN1, MFN2 and DRP1 polymorphisms are associated with risk of lung cancer. Pharmgenomics Pers Med. 2021;695\u2013703.","DOI":"10.2147\/PGPM.S314860"},{"key":"882_CR31","doi-asserted-by":"crossref","unstructured":"Yu CX, et al. p32\/OPA1 axis-mediated mitochondrial dynamics contributes to cisplatin resistance in non-small cell lung cancer. Acta Biochim Biophys Sin (Shanghai). 2024;56(1):34\u201343.","DOI":"10.3724\/abbs.2023247"},{"key":"882_CR32","doi-asserted-by":"crossref","unstructured":"Chung KP, et al. Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1. Mol Oncol. 2021;560\u2013578.","DOI":"10.1002\/1878-0261.12843"},{"key":"882_CR33","doi-asserted-by":"crossref","unstructured":"Mirzapoiazova T, et al. Teriflunomide\/leflunomide synergize with chemotherapeutics by decreasing mitochondrial fragmentation via DRP1 in SCLC. iScience. 2024;110132.","DOI":"10.1016\/j.isci.2024.110132"},{"key":"882_CR34","doi-asserted-by":"crossref","unstructured":"Kim YY, Yun SH, Yun J. Downregulation of Drp1, a fission regulator, is associated with human lung and colon cancers. Acta Biochim Biophys Sin (Shanghai). China; 2018. pp. 209\u201315.","DOI":"10.1093\/abbs\/gmx137"},{"key":"882_CR35","doi-asserted-by":"crossref","unstructured":"Deng X et al. Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway. nt J Biol Sci. 2020;1403\u20131416.","DOI":"10.7150\/ijbs.41768"},{"key":"882_CR36","doi-asserted-by":"crossref","unstructured":"Ding R, et al. QiDongNing induces lung cancer cell apoptosis via triggering P53\/DRP1-mediated mitochondrial fission. J Cell Mol Med. 2024;e18353.","DOI":"10.1111\/jcmm.18353"},{"key":"882_CR37","doi-asserted-by":"crossref","unstructured":"Ma J, et al. Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer. Cancer Immunol Immunother. Germany; 2024. p. 40.","DOI":"10.1007\/s00262-023-03582-5"},{"issue":"4","key":"882_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12032-015-0515-0","volume":"32","author":"Y Lou","year":"2015","unstructured":"Lou Y, et al. Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma. Med Oncol. 2015;32(4):132.","journal-title":"Med Oncol"},{"key":"882_CR39","doi-asserted-by":"crossref","unstructured":"Zhang J, et al. MFN2 deficiency affects calcium homeostasis in lung adenocarcinoma cells via downregulation of UCP. FEBS Open Bio. England; 2023;4:1107\u201324.","DOI":"10.1002\/2211-5463.13591"},{"issue":"4","key":"882_CR40","first-page":"1047","volume":"4","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Shenmai injection enhances cisplatin-induced apoptosis through regulation of Mfn2-dependent mitochondrial dynamics in lung adenocarcinoma A549\/DDP cells. Cancer Drug Resist. 2021;4(4):1047\u201360.","journal-title":"Cancer Drug Resist"},{"issue":"9","key":"882_CR41","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.stem.2022.07.010","volume":"29","author":"N Baker","year":"2022","unstructured":"Baker N, et al. The mitochondrial protein OPA1 regulates the quiescent state of adult muscle stem cells. Cell Stem Cell. 2022;29(9):1315\u201332. e9.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"882_CR42","doi-asserted-by":"publisher","first-page":"e158429","DOI":"10.1172\/jci.insight.158429","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, et al. Lipogenesis promotes mitochondrial fusion and maintains cancer stemness in human NSCLC. JCI insight. 2023;8(6):e158429.","journal-title":"JCI insight"},{"key":"882_CR43","doi-asserted-by":"crossref","unstructured":"Wang Y, et al. OPA1 supports mitochondrial dynamics and immune evasion to CD8(+) T cell in lung adenocarcinoma. PeerJ. United States; 2022;e14543.","DOI":"10.7717\/peerj.14543"},{"issue":"11","key":"882_CR44","doi-asserted-by":"publisher","first-page":"111818","DOI":"10.1016\/j.celrep.2022.111818","volume":"41","author":"DT Sessions","year":"2022","unstructured":"Sessions DT, et al. Opa1 and Drp1 reciprocally regulate cristae morphology, ETC function, and NAD(+) regeneration in KRas-mutant lung adenocarcinoma. Cell Rep. 2022;41(11):111818.","journal-title":"Cell Rep"},{"key":"882_CR45","doi-asserted-by":"publisher","first-page":"e14543","DOI":"10.7717\/peerj.14543","volume":"10","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. OPA1 supports mitochondrial dynamics and immune evasion to CD8\u2009+\u2009T cell in lung adenocarcinoma. PeerJ. 2022;10:e14543.","journal-title":"PeerJ"},{"key":"882_CR46","doi-asserted-by":"crossref","unstructured":"Dutkowska A, et al. Mitochondrial dynamics in non-small cell lung cancer. Cancers (Basel). Switzerland; 2024.","DOI":"10.3390\/cancers16162823"},{"key":"882_CR47","doi-asserted-by":"crossref","unstructured":"Colonna MB, et al. Functional assessment of homozygous ALDH18A1 variants reveals alterations in amino acid and antioxidant metabolism. Hum Mol Genet. England; 2023;732\u201344.","DOI":"10.1093\/hmg\/ddac226"},{"issue":"8","key":"882_CR48","first-page":"1007","volume":"1812","author":"T Varga","year":"2011","unstructured":"Varga T, Czimmerer Z, Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim et Biophys Acta (BBA)-Molecular Basis Disease. 2011;1812(8):1007\u201322.","journal-title":"Biochim et Biophys Acta (BBA)-Molecular Basis Disease"},{"issue":"4","key":"882_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/ijms19040949","volume":"19","author":"S Lamichane","year":"2018","unstructured":"Lamichane S, Dahal Lamichane B, Kwon S-M. Pivotal roles of peroxisome proliferator-activated receptors (PPARs) and their signal cascade for cellular and whole-body energy homeostasis. Int J Mol Sci. 2018;19(4):949.","journal-title":"Int J Mol Sci"},{"key":"882_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ceb.2014.11.002","volume":"33","author":"W Fan","year":"2015","unstructured":"Fan W, Evans R. PPARs and ERRs: molecular mediators of mitochondrial metabolism. Curr Opin Cell Biol. 2015;33:49\u201354.","journal-title":"Curr Opin Cell Biol"},{"key":"882_CR51","doi-asserted-by":"publisher","first-page":"p1830626","DOI":"10.1155\/2017\/1830626","volume":"2017","author":"D Fanale","year":"2017","unstructured":"Fanale D, Amodeo V, Caruso S. The interplay between metabolism, PPAR signaling pathway, and cancer. PPAR Res. 2017;2017:p1830626.","journal-title":"PPAR Res"},{"key":"882_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ebiom.2019.02.015","volume":"41","author":"TN Hua","year":"2019","unstructured":"Hua TN, et al. Inhibition of oncogenic Src induces FABP4-mediated lipolysis via PPAR\u03b3 activation exerting cancer growth suppression. EBioMedicine. 2019;41:134\u201345.","journal-title":"EBioMedicine"},{"issue":"5","key":"882_CR53","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.21037\/tlcr-24-1027","volume":"14","author":"H Tian","year":"2025","unstructured":"Tian H, et al. Impaired natural killer cell maturation in lung adenocarcinoma driven by FABP4 and SPON2 downregulation through disrupted lipid metabolism. Translational Lung Cancer Res. 2025;14(5):1660.","journal-title":"Translational Lung Cancer Res"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00882-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00882-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00882-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:56:56Z","timestamp":1790819816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00882-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["882"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00882-5","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments conformed to the Guide for the Care and Use of Laboratory Animals. Animal study has been approved by the Animal Ethics Committee of the Affiliated Guangdong Second Provincial General Hospital of Jinan University.(No. 2025-DW-KZ-142-01). All methods are reported in accordance with ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"189"}}